Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aceragen, Inc (ACGN)  
$0.38 0.00 (0.00%) as of 4:30 Mon 8/21


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 8,423,000
Market Cap: 3.20(M)
Last Volume: 1,933,173 Avg Vol: 663,431
52 Week Range: $0.38 - $1.85
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Idera Pharmaceuticals is a biopharmaceutical company focused on the clinical development, and the commercialization, of drug candidates for rare disease indications characterized by patient populations with unmet medical needs. Co.'s focus is to identify and acquire rights to development and commercial stage rare disease programs through new business development opportunities, including additional alternatives. Co. is evaluating intratumoral tilsotolimod in combination with nivolumab, an anti-Progressive Disease 1 antibody marketed as Opdivo® by Bristol Myers Squibb Company, and ipilimumab for the treatment of multiple solid tumors in a multicohort trial.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 26,965 26,965
Total Buy Value $0 $0 $38,290 $38,290
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 273,476 273,476
Total Sell Value $0 $0 $420,198 $420,198
Total People Sold 0 0 4 4
Total Sell Transactions 0 0 9 9
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 234
  Page 7 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baker Julian Director   –       •      –    2017-10-26 4 B $1.50 $12,000,000 I/I 8,000,000 16,557,473 2.1     -
   Zein Youssef El Director   –       •       •   2017-10-16 4 OE $0.00 $0 I/I 6,842,844 0     -
   Baker Julian Director   –       •      –    2017-10-02 4 A $2.28 $61,868 I/I 27,135 154,498     -
   Zein Youssef El Director   –       •       •   2017-10-02 4 A $2.28 $10,764 D/D 4,721 534,980     -
   Zein Youssef El Director   –       •       •   2017-07-03 4 A $1.75 $10,764 D/D 6,151 530,259     -
   Reardon William S Director   –       •      –    2017-07-03 4 A $1.75 $13,500 D/D 7,714 32,973     -
   Baker Felix Director   –       •      –    2017-07-03 4 A $1.75 $61,882 I/I 35,361 145,453     -
   Zein Youssef El Director   –       •       •   2017-05-01 4 OE $0.00 $0 I/I 409,237 0     -
   Zein Youssef El Director   –       •       •   2017-05-01 4 AS $2.26 $1,018,436 I/I (450,815) 0     -
   Zein Youssef El Director   –       •       •   2017-04-25 4 AS $2.29 $2,037,944 I/I (890,593) 0     -
   Zein Youssef El Director   –       •       •   2017-04-24 4 AS $2.29 $1,002,059 I/I (437,829) 0     -
   Zein Youssef El Director   –       •       •   2017-04-03 4 A $2.43 $10,765 D/D 4,430 528,538     -
   667, L.p. Director   –       •      –    2017-04-03 4 A $2.43 $61,870 I/I 25,461 133,666     -
   Zein Youssef El Director   –       •       •   2017-01-04 4 A $1.50 $10,824 D/D 7,216 524,108     -
   Gowen Maxine Director   –       •      –    2017-01-04 4 A $1.50 $10,500 D/D 7,000 17,543     -
   667, L.p. Director   –       •      –    2017-01-03 4 A $1.50 $63,761 I/I 42,507 125,179     -
   Zein Youssef El Director   –       •       •   2016-11-03 4 OE $0.00 $0 I/I 1,370,000 0     -
   Gowen Maxine Director   –       •      –    2016-10-16 5 GA $0.00 $0 D/D 10,542 1     -
   Pillar Pharmaceuticals V Lp Director   –       •       •   2016-10-07 3 IO $0.00 $0 D/D 0 875,000     -
   667, L.p. Director   –       •      –    2016-10-07 4 B $2.00 $6,500,000 I/I 3,250,000 9,309,333 2.1     -
   667, L.p. Director   –       •      –    2016-10-03 4 A $2.56 $63,736 I/I 24,897 111,010     -
   Gowen Maxine Director   –       •      –    2016-10-03 4 B $2.56 $10,501 D/D 4,102 10,543 2.39     -
   Zein Youssef El Director   –       •       •   2016-10-03 4 B $2.56 $10,824 D/D 4,228 516,892 3.92     -
   Reardon William S Director   –       •      –    2016-07-01 4 A $1.63 $6,686 D/D 4,102 25,259     -
   Gowen Maxine Director   –       •      –    2016-07-01 4 A $1.63 $10,499 D/D 6,441 6,441     -
  234 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us